Elevated homocysteine and hypertension in Xinjiiang Province, China

Ethnicity and Disease

Volumn 20, Issue 1, 2010, Pages 7-10

  Lu, Hang ^a   Lu, Zhen Hong ^b   Li, Peng Gang ^c   Wang, Ying Ying ^d   Yan, Zhao Yang ^b  

^a Urumqi Third People Hospital   (China)

^b Xinjiang Industrial College   (China)

^c Urumqi Stomatological Affiliated Hospital   (China)

^d Traditional Chinese Medical Hospital of Xinjiang Uygur Autonomous Region   (China)

Author keywords

Cardiovascular disease; China; Homocysteine; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CHINESE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; SYSTOLIC BLOOD PRESSURE; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CHINA; ETHNOLOGY; MIDDLE AGED; PREVALENCE;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHINA; FEMALE; HOMOCYSTEINE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 77951638280     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol. 1996;27(3):517-527.
2. Tanne D, Haim M, Goldbourt U, Boyko V, et al. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke. 2003;34(3):632-636.
3. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst( e)ine and risk of myocardial infarction in US physicians. JAMA. 1992;268(7):877-881.
4. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324(17):1149-1155.
5. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288(16):2015-2022.
6. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. European Concerted Action Project. JAMA. 1997;277(22):1775-1781.
7. Lu Z, Lu Z, Zhu Y, et al. Enhanced hypertension prevalence in non-Han Chinese minorities from Xinjiang Province,China. Hypertens Res. 2009;[Epub ahead of print].
8. Lu ZS, Lu ZH, Lu H, et al. Association between hyperuricemia and hypertension in a Chinese population at a high risk of hypertension. Blood Press. 2009;18(5):268-272.
9. Liu Y, Li X, Peng D, et al. Usefulness of serum cathepsin L as an independent biomarker in patients with coronary heart disease. Am J Cardiol. 2009;103(4):476-481.
10. Bortolotto LA, Safar ME, Billaud E, et al. Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. Hypertension. 1999;34(4 Pt 2):837-842.
11. Appel LJ, Obarzanek E, Vollmer WM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336(16):1117-1124.
12. van Guldener C, Nanayakkara PW, Stehouwer CD. Homocysteine and blood pressure. Curr Hypertens Rep. 2003;5(1):26-31.
13. Sutton-Tyrrell K, Bostom A, Selhub J, Zeigler-Johnson C. High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation. 1997;96(6):1745-1749.
14. Lim U, Cassano PA. Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2002;156(12):1105-1113.
15. Dinavahi R, Cossrow N, Kushner H, Falkner B. Plasma Homocysteine Concentration and Blood Pressure in Young Adult African Americans. Am J Hypertens. 2003;16(9 Pt 1):767-770.
16. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation. 1997;95(5):1119-1121.
17. Kahleova R, Palyzova D, Zvara K, et al. Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitamins. Am J Hypertens. 2002;15(10 Pt 1):857-864.
18. Mujumdar VS, Aru GM, Tyagi SC. Induction of oxidative stress by homocyst(e)ine impairs endothelial function. J Cell Biochem. 2001;82(3):491-500. (Pubitemid 32729412)
19. Chambers JC, McGregor A, Jean-Marie J, Kooner JS. Acute hyperhomocysteinaemia endothelial dysfunction. Lancet. 1998;351(9095):36-37.
20. Sundström J, Sullivan L, D'Agostino RB, et al. Plasma homocysteine, hypertension incidence, and blood pressure rracking: the Framingham Heart Study. Hypertension. 2003;42(6):1100-1105.
21. Lonn E, Yusuf S, Arnold MJ, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;355(7):746.
22. Bonaa KH, Njolstad I, Ueland PM, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354(15):1578-1588.
23. Bazzano LA, He J, Ogden LG, et al. Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow-Up Study: National Health and Nutrition Examination Survey. Stroke. 2002;33(5):1183-1189.
24. Jacques PF, Selhub J, Bostom AG, Wilson PWF, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med. 1999;340(19):1449-1454. (Pubitemid 29220543)
25. Appel LJ, Miller ERIII, Jee SH, et al. Effect of dietary patterns on serum homocysteine: results of a randomized, controlled feeding study. Circulation. 2000;102(8):852-857.
26. Bazzano LA, Reynolds K, Holder KN, He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA. 2006;296(22):2720-2726. (Pubitemid 44917549)
27. Lange H, Suryapranata H, De Luca G, et al. Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med. 2004;350(26):2673-2681. (Pubitemid 38788002)
28. Bleie Ø, Ueland PM, Nordrehaug JE, et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA. 2008;300(7):795-804.